Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT05808920. IPD Sharing: NO. Countries: 1. Publications: 0.
Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06142318. IPD Sharing: NO. Countries: 1. Publications: 0.
De-Intensification of Postoperative Radiotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT06030440. IPD Sharing: NO. Countries: 1. Publications: 0.
Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01425736. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02270814. IPD Sharing: NO. Countries: 1. Publications: 0.
Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04284540. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01015664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05784012. IPD Sharing: NO. Countries: 1. Publications: 0.
Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy
ClinicalTrials.gov study NCT03114163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07320690. IPD Sharing: NO. Countries: 1. Publications: 0.
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
ClinicalTrials.gov study NCT04966481. IPD Sharing: NO. Countries: 1. Publications: 0.
Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma )
ClinicalTrials.gov study NCT03975270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexi
ClinicalTrials.gov study NCT03161613. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00903461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06790966. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00079053. IPD Sharing: NO. Countries: 1. Publications: 0.
Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03519048. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
ClinicalTrials.gov study NCT06856213. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intra
ClinicalTrials.gov study NCT05005403. IPD Sharing: NO. Countries: 5. Publications: 0.
A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)
ClinicalTrials.gov study NCT05068609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.